Coating Place, Inc. has developed and manufactured modified release oral dosage products since 1976. We are the leading provider of Wurster fluid bed microencapsulation. Our services include formulation development, technology transfer, scale-up and commercial manufacturing in a GMP environment. Our facility processes solvent and aqueous formulations. Other services offered are capsule filling, tablet compression, pan coating, extrusion spheronisation and roller compaction. We are registered with the FDA and licensed by the DEA.
With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.
Direct to patient logistics include clinical drug storage, direct-to-patient delivery, biologic sample collection, central pharmacy and nursing services
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor